Indonesian pharmaceutical manufacturer with public market presence and halal-certified operations
Darya-Varia is a publicly listed Indonesian pharmaceutical company operating since 1976 with two cGMP-certified manufacturing plants. The tech stack is enterprise-focused (SAP, Coopa, Google Analytics) rather than engineering-forward, and hiring is minimal (zero posts in the past month), with headcount concentrated in marketing, operations, and finance—a shape typical of mature manufacturing operations prioritizing compliance and cost control over product innovation. Active projects center on e-commerce, brand performance, and regulatory certification, while internal pain points cluster around forecast accuracy, operational gaps, and cash management.
PT Darya-Varia Laboratoria Tbk manufactures and distributes pharmaceutical products across Indonesia, operating two manufacturing facilities in Gunung Putri and Citeureup that meet international cGMP standards and BPOM (Indonesian food and drug authority) requirements. The company is publicly traded on the Indonesia Stock Exchange (ticker: DVLA) and has maintained halal certification across all products and facilities. The product portfolio spans both over-the-counter healthcare goods and prescription pharmaceuticals, with go-to-market activity spanning traditional retail, e-commerce channels (including Shopee), and performance marketing.
Two plants in Gunung Putri and Citeureup certified to cGMP and BPOM standards. All products and facilities maintain halal certification via an implemented halal assurance system.
Tech stack includes Google Analytics, Google Ads, Meta Business Suite, and TikTok. Active projects span e-commerce strategy, Shopee store optimization, livestream coordination, and performance marketing ROI.
Other companies in the same industry, closest in size